NBP
NovaBridge Biosciences NASDAQ Listed Jan 17, 2020$2.22
Mkt Cap $255.9M
52w Low $0.83
23.3% of range
52w High $6.79
50d MA $2.71
200d MA $3.68
P/E (TTM)
-5.0x
EV/EBITDA
-26.3x
P/B
0.1x
Debt/Equity
0.0x
ROE
-20.0%
P/FCF
-129.4x
RSI (14)
—
ATR (14)
—
Beta
1.74
50d MA
$2.71
200d MA
$3.68
Avg Volume
810.5K
NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. The company was formerly known as I-Mab and change its name to NovaBridge Biosciences in October 2025. NovaBridge Biosciences was founded in 2014 and is headquartered in Rockville, Maryland.
2440 Research Boulevard · Rockville, MD 20850 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | AMC | -0.01 | -0.03 | -528.3% | 2.48 | +5.6% | -1.2% | -0.8% | -2.9% | +1.7% | +5.8% | — |
| Dec 18, 2025 | AMC | -0.01 | -0.25 | -1801.5% | 3.96 | +0.5% | +5.8% | +4.8% | +2.5% | +2.9% | -6.3% | — |
| Nov 12, 2025 | AMC | -0.04 | -0.01 | +76.5% | 4.22 | -0.9% | -1.2% | -0.5% | +5.3% | +3.9% | -0.2% | — |
| May 15, 2025 | AMC | -0.06 | -0.04 | +33.3% | 0.89 | -3.1% | +1.7% | +1.2% | +0.3% | +3.2% | +11.3% | — |
| Apr 4, 2025 | AMC | -0.06 | -0.11 | -83.3% | 0.68 | +13.2% | -8.8% | +10.6% | +0.4% | -2.1% | -0.7% | — |
| Nov 14, 2024 | AMC | -0.16 | -0.25 | -56.2% | 1.07 | +1.9% | -2.8% | -2.9% | -5.6% | +2.8% | -2.1% | — |
| Aug 28, 2024 | AMC | -0.51 | -0.07 | +86.3% | 1.17 | +0.9% | -4.3% | +0.9% | -7.1% | +0.0% | +0.0% | — |
| Jun 5, 2024 | AMC | — | 0.04 | — | 1.90 | +0.5% | -1.6% | +0.5% | -1.1% | +0.0% | -0.5% | — |
| Mar 29, 2024 | AMC | -0.10 | -0.59 | -513.0% | — | — | — | — | — | — | — | — |
| Sep 30, 2023 | AMC | — | -0.57 | — | — | — | — | — | — | — | — | — |
| Aug 17, 2023 | AMC | -0.26 | -0.64 | -146.7% | 2.30 | -0.4% | -8.7% | -9.3% | +3.7% | -0.8% | -3.6% | — |
| Mar 31, 2023 | AMC | -0.49 | -0.68 | -37.9% | 3.46 | +1.7% | +6.4% | -1.4% | -2.5% | +8.8% | -7.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.48 | $2.62 | +5.6% | -1.2% | -0.8% | -2.9% | +1.7% | +5.8% |
| Mar 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.83 | $3.10 | +9.5% | +2.5% | -0.7% | -2.1% | -4.6% | -4.8% |
| Feb 6 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.33 | $3.47 | +4.2% | +11.1% | -6.2% | -1.4% | -0.9% | -4.4% |
| Oct 24 | BTIG | Maintains | Buy → Buy | — | $4.39 | $4.40 | +0.2% | -3.9% | +11.4% | -1.3% | -0.2% | -1.7% |
| Oct 17 | BTIG | Maintains | Buy → Buy | — | $6.56 | $6.30 | -4.0% | -12.0% | -9.5% | -1.7% | -6.0% | -8.9% |
| Sep 10 | BTIG | Maintains | Buy → Buy | — | $4.60 | $4.25 | -7.6% | -9.1% | -6.7% | +4.9% | -11.5% | +2.8% |
| Sep 8 | Needham | Maintains | Buy → Buy | — | $4.38 | $4.43 | +1.1% | -2.5% | +7.7% | -9.1% | -6.7% | +4.9% |
| Aug 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.52 | $4.38 | -3.1% | +4.2% | +8.1% | -5.3% | +7.5% | -13.1% |
| Aug 20 | Needham | Maintains | Buy → Buy | — | $4.21 | $4.15 | -1.4% | +7.4% | +4.2% | +8.1% | -5.3% | +7.5% |
| Jul 9 | Needham | Maintains | Buy → Buy | — | $2.20 | $2.22 | +0.9% | +5.0% | -11.3% | +3.9% | +0.5% | -1.9% |
| Jul 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.20 | $2.22 | +0.9% | +5.0% | -11.3% | +3.9% | +0.5% | -1.9% |
| Jun 27 | Needham | Maintains | Buy → Buy | — | $2.02 | $2.12 | +5.0% | +27.2% | -5.8% | -3.3% | -2.1% | -6.1% |
| Sep 24 | Needham | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Sep 4 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | — | — | — | — | — | — | — | — |
| Aug 17 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $2.37 | $2.51 | +5.9% | -3.0% | -8.7% | -9.3% | +3.7% | -0.8% |
| Aug 17 | Needham | Maintains | Buy → Buy | — | $2.37 | $2.51 | +5.9% | -3.0% | -8.7% | -9.3% | +3.7% | -0.8% |
| Aug 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.37 | $2.51 | +5.9% | -3.0% | -8.7% | -9.3% | +3.7% | -0.8% |
| Jun 4 | Needham | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Apr 19 | Needham | Maintains | Buy → Buy | — | $3.42 | $3.30 | -3.5% | -0.6% | -5.6% | +4.4% | -5.1% | -1.3% |
| Apr 2 | Piper Sandler | Maintains | Overweight → Overweight | — | — | — | — | — | — | — | — | — |
| Apr 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Apr 2 | Needham | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Aug 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.83 | $6.02 | +3.3% | +2.6% | +2.5% | +2.6% | -6.0% | -5.4% |
| Aug 30 | Needham | Maintains | Buy → Buy | — | $5.83 | $6.02 | +3.3% | +2.6% | +2.5% | +2.6% | -6.0% | -5.4% |
| Aug 29 | Piper Sandler | Maintains | Overweight → Overweight | — | $6.00 | $5.80 | -3.3% | -2.8% | +2.6% | +2.5% | +2.6% | -6.0% |
| Aug 16 | Needham | Maintains | Buy → Buy | — | $7.97 | $7.90 | -0.9% | +0.0% | -14.3% | -9.4% | -2.9% | -4.3% |
| May 30 | Needham | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| May 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Mar 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.85 | $17.04 | +1.1% | +15.1% | -2.3% | -14.3% | +7.8% | +5.3% |
| Oct 31 | Needham | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Aug 31 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $64.18 | $62.84 | -2.1% | +10.5% | +1.3% | -1.0% | +0.8% | +4.0% |
| Jun 9 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $74.11 | $73.97 | -0.2% | +2.6% | -3.6% | -2.1% | +0.9% | -3.0% |
| Jun 2 | Daiwa Capital | Maintains | Buy → Buy | — | $80.00 | $81.40 | +1.8% | -4.8% | -0.1% | +2.5% | -4.5% | -0.6% |
| Mar 15 | Needham | Maintains | Buy → Buy | — | $55.01 | $56.80 | +3.3% | -4.3% | +3.9% | +3.7% | -6.1% | -0.5% |
| Mar 3 | H.C. Wainwright | Maintains | Buy → Buy | — | $58.90 | $59.67 | +1.3% | +4.0% | -9.3% | -11.3% | +1.5% | +2.5% |
| Mar 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $63.97 | $63.55 | -0.7% | -7.9% | +4.0% | -9.3% | -11.3% | +1.5% |
| Mar 2 | H.C. Wainwright | Maintains | Buy → Buy | — | $63.97 | $63.55 | -0.7% | -7.9% | +4.0% | -9.3% | -11.3% | +1.5% |
| Feb 25 | Piper Sandler | Maintains | Overweight → Overweight | — | $57.99 | $59.59 | +2.8% | +0.8% | +1.2% | +8.1% | -7.9% | +4.0% |
| Dec 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $37.99 | $39.27 | +3.4% | +7.2% | -5.5% | -1.4% | -2.4% | +0.2% |
| Aug 26 | CMB International | Maintains | Buy → Buy | — | $30.28 | $31.09 | +2.7% | -0.3% | +3.5% | -0.8% | +27.2% | -11.3% |
| Jul 27 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $28.24 | $29.65 | +5.0% | +5.5% | +2.4% | -1.0% | -2.7% | +8.7% |
| Feb 14 | CICC | Maintains | Outperform → Outperform | — | $11.08 | $11.15 | +0.6% | -2.4% | -1.7% | +0.1% | +14.1% | -1.2% |
| Feb 12 | China Renaissance | Maintains | Buy → Buy | — | $11.18 | $11.20 | +0.2% | -1.6% | +0.7% | -2.4% | -1.7% | +0.1% |
| Feb 11 | Jefferies | Maintains | Buy → Buy | — | $11.00 | $11.26 | +2.4% | +1.6% | -1.6% | +0.7% | -2.4% | -1.7% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | Hagler Mark Arnold | See Remarks | Buy | 230,000 | $2.51 | $577K | 230,000 | -1.67% | +1.46% |
No recent filings available.
Data updated apr 26, 2026 2:21pm
· Source: massive.com